|
1
|
Magrath I and Litvak J: Cancer in
developing countries: Opportunity and challenge. J Natl Cancer
Inst. 85:862–874. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuen AP, Lam KY, Chan AC, Wei WI, Lam LK,
Ho WK and Ho CM: Clinicopathological analysis of elective neck
dissection for N0 neck of early oral tongue carcinoma. Am J Surg.
177:90–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Layland MK, Sessions DG and Lenox J: The
influence of lymph node metastasis in the treatment of squamous
cell carcinoma of the oral cavity, oropharynx, larynx, and
hypopharynx: N0 versus N+. Laryngoscope. 115:629–639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bilancio A, Bontempo P, Di Donato M, Conte
M, Giovannelli P, Altucci L, Migliaccio A and Castoria G: Bisphenol
A induces cell cycle arrest in primary and prostate cancer cells
through EGFR/ERK/p53 signaling pathway activation. Oncotarget.
8:115620–115631. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tripathi K and Garg M: Mechanistic
regulation of epithelial-to-mesenchymal transition through RAS
signaling pathway and therapeutic implications in human cancer. J
Cell Commun Signal. 12:513–527. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Z, Wang J, Pan Z and Zhang Y:
miR-143-3p regulates cell proliferation and apoptosis by targeting
IGF1R and IGFBP5 and regulating the Ras/p38 MAPK signaling pathway
in rheumatoid arthritis. Exp Ther Med. 15:3781–3790.
2018.PubMed/NCBI
|
|
8
|
Song K, Zheng G and Zhao Y: Liver kinase
B1 suppresses growth of lung cancer cells through sonic hedgehog
signaling pathway. Cell Biol Int. 42:994–1005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fracalossi AC, Silva MS, Oshima CT and
Ribeiro DA: Wnt/beta-catenin signalling pathway following rat
tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Mol
Pathol. 88:176–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bondos S: Variations on a theme: Hox and
Wnt combinatorial regulation during animal development. Sci Stke
2006. pe382006.
|
|
11
|
Cadigan KM and Nusse R: Wnt signaling: A
common theme in animal development. Genes Dev. 11:3286–3305. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiao J, Zhao X, Liang Y, Tang D and Pan C:
FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC)
metastasis through epithelial-mesenchymal transition (EMT). Biochem
Biophys Res Commun. 466:327–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang H, Sun JD, Yan LJ and Zhao XP:
PDGF-D/PDGFRbeta promotes tongue squamous carcinoma cell (TSCC)
progression via activating p38/AKT/ERK/EMT signal pathway. Biochem
Biophys Res Commun. 478:845–851. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu L, Wu B, Cai H, Li D, Ma Y, Zhu X, Lv
Z, Fan Y and Zhang X: Tiam1 promotes thyroid carcinoma metastasis
by modulating EMT via Wnt/β-catenin signaling. Exp Cell Res.
362:532–540. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui D, Zhao Y and Xu J: Activated
CXCL5-CXCR2 axis promotes the migration, invasion and EMT of
papillary thyroid carcinoma cells via modulation of beta-catenin
pathway. Biochimie. 148:1–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghahhari NM and Babashah S: Interplay
between microRNAs and WNT/beta-catenin signalling pathway regulates
epithelial-mesenchymal transition in cancer. Eur J Cancer.
51:1638–1649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nie X, Liu Y, Chen WD and Wang YD:
Interplay of miRNAs and canonical wnt signaling pathway in
hepatocellular carcinoma. Front Pharmacol. 9:6572018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshioka S, King ML, Ran S, Okuda H,
MacLean JA II, McAsey ME, Sugino N, Brard L, Watabe K and Hayashi
K: WNT7A regulates tumor growth and progression in ovarian cancer
through the WNT/β-catenin pathway. Mol Cancer Res. 10:469–482.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Avgustinova A, Iravani M, Robertson D,
Fearns A, Gao Q, Klingbeil P, Hanby AM, Speirs V, Sahai E, Calvo F
and Isacke CM: Tumour cell-derived Wnt7a recruits and activates
fibroblasts to promote tumour aggressiveness. Nat Commun.
7:103052016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirikoshi H and Katoh M: Expression of
WNT7A in human normal tissues and cancer, and regulation of
WNT7A, WNT7B in human cancer. Int J Oncol. 21:895–900.
2002.PubMed/NCBI
|
|
21
|
Bikkavilli RK, Avasarala S, Van Scoyk M,
Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T,
Tauler J, et al: Wnt7a is a novel inducer of β-catenin-independent
tumor-suppressive cellular senescence in lung cancer. Oncogene.
34:54062015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sato N, Fukushima N, Maitra A,
Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH and Goggins M:
Discovery of novel targets for aberrant methylation in pancreatic
carcinoma using high-throughput microarrays. Cancer Res.
63:3735–3742. 2003.PubMed/NCBI
|
|
23
|
Zhang XL, Peng CJ, Peng J, Jiang LY, Ning
XM and Zheng JH: Prognostic role of Wnt7a expression in ovarian
carcinoma patients. Neoplasma. 57:545–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang X, Zhu H, Gao Z, Li J, Zhuang J,
Dong Y, Shen B, Li M, Zhou H, Guo H, et al: Wnt7a activates
canonical Wnt signaling, promotes bladder cancer cell invasion, and
is suppressed by miR-370-3p. J Biol Chem. 293:6693–6706. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paluszczak J, Kiwerska K and
Mielcarek-Kuchta D: Frequent methylation of DAB2, a Wnt
pathway antagonist, in oral and oropharyngeal squamous cell
carcinomas. Pathol Res Pract. 214:314–317. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hema KN, Smitha T, Sheethal HS and
Mirnalini SA: Epigenetics in oral squamous cell carcinoma. J Oral
Maxillofac Pathol. 21:252–259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Farooqi AA, Shu CW, Huang HW, Wang HR,
Chang YT, Fayyaz S, Yuan SF, Tang JY and Chang HW: TRAIL, Wnt,
Sonic Hedgehog, TGFβ, and miRNA signalings are potential targets
for oral cancer therapy. Int J Mol Sci. 18(pii): E15232017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gonzalez-Moles MA, Ruiz-Avila I,
Gil-Montoya JA, Plaza-Campillo J and Scully C: β-catenin in oral
cancer: An update on current knowledge. Oral Oncol. 50:818–824.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noguti J, DE Moura CF, Hossaka TA, Franco
M, Oshima CT, Dedivitis RA and Ribeiro DA: The role of canonical
WNT signaling pathway in oral carcinogenesis: A comprehensive
review. Anticancer Res. 32:873–878. 2012.PubMed/NCBI
|
|
31
|
Enokida T, Fujii S, Takahashi M, Higuchi
Y, Nomura S, Wakasugi T, Yamazaki T, Hayashi R, Ohtsu A and Tahara
M: Gene expression profiling to predict recurrence of advanced
squamous cell carcinoma of the tongue: Discovery and external
validation. Oncotarget. 8:61786–61799. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shetty AV and Wong DJ: Systemic treatment
for squamous cell carcinoma of the head and neck. Otolaryngol Clin
North Am. 50:775–782. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Almangush A, Heikkinen I, Makitie AA,
Coletta RD, Läärä E, Leivo I and Salo T: Prognostic biomarkers for
oral tongue squamous cell carcinoma: A systematic review and
meta-analysis. Br J Cancer. 117:856–866. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev CanceR. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vig N, Mackenzie IC and Biddle A:
Phenotypic plasticity and epithelial-to-mesenchymal transition in
the behaviour and therapeutic response of oral squamous cell
carcinoma. J Oral Pathol Med. 44:649–655. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vincan E and Barker N: The upstream
components of the Wnt signalling pathway in the dynamic EMT and MET
associated with colorectal cancer progression. Clin Exp Metastasis.
25:657–663. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Y, Meng F, Xu Y, Yang S, Xiao M, Chen
X and Lou G: Overexpression of Wnt7a is associated with tumor
progression and unfavorable prognosis in endometrial cancer. Int J
Gynecol Cancer. 23:304–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Peng C, Zhang X, Wang Y, Li L, Wang Q and
Zheng J: Expression and prognostic significance of wnt7a in human
endometrial carcinoma. Obstet Gynecol Int 2012. 1349622012.
|
|
41
|
King ML, Lindberg ME, Stodden GR, Okuda H,
Ebers SD, Johnson A, Montag A, Lengyel E, MacLean Ii JA and Hayashi
K: WNT7A/β-catenin signaling induces FGF1 and influences
sensitivity to niclosamide in ovarian cancer. Oncogene.
34:3452–3462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tulac S, Nayak NR, Kao LC, Van Waes M,
Huang J, Lobo S, Germeyer A, Lessey BA, Taylor RN, Suchanek E, et
al: Identification, characterization, and regulation of the
canonical Wnt signaling pathway in human endometrium. J Clin
Endocrinol Metab. 88:3860–3866. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miller C and Sassoon DA: Wnt-7a maintains
appropriate uterine patterning during the development of the mouse
female reproductive tract. Development. 125:3201–3211.
1998.PubMed/NCBI
|
|
44
|
Hayashi K, Erikson DW, Tilford SA, Bany
BM, Maclean JA II, Rucker EB III, Johnson GA and Spencer TE: Wnt
genes in the mouse uterus: Potential regulation of implantation.
Biol Reprod. 80:989–1000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Merritt MA, Parsons PG, Newton TR, Martyn
AC, Webb PM, Green AC, Papadimos DJ and Boyle GM: Expression
profiling identifies genes involved in neoplastic transformation of
serous ovarian cancer. BMC Cancer. 9:3782009. View Article : Google Scholar : PubMed/NCBI
|
